Development
HCA Healthcare, Inc.
HCA
$376.86
$4.411.18%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 1.61B | 1.08B | 1.19B | 1.36B | 2.08B |
| Total Depreciation and Amortization | 789.00M | 769.00M | 763.00M | 756.00M | 750.00M |
| Total Amortization of Deferred Charges | 9.00M | 9.00M | 8.00M | 9.00M | 7.00M |
| Total Other Non-Cash Items | 495.00M | 353.00M | -31.00M | 717.00M | -237.00M |
| Change in Net Operating Assets | -226.00M | 269.00M | 542.00M | -1.04B | -74.00M |
| Cash from Operations | 2.67B | 2.48B | 2.48B | 1.80B | 2.53B |
| Capital Expenditure | -1.16B | -1.15B | -1.24B | -1.20B | -1.32B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -354.00M | -157.00M | -9.00M | -115.00M | -48.00M |
| Divestitures | 10.00M | 11.00M | 7.00M | 165.00M | 585.00M |
| Other Investing Activities | -94.00M | -19.00M | -14.00M | -4.00M | -7.00M |
| Cash from Investing | -1.60B | -1.31B | -1.26B | -1.15B | -793.00M |
| Total Debt Issued | 4.00M | 2.00M | 1.98B | 1.24B | 141.00M |
| Total Debt Repaid | 182.00M | 337.00M | -1.90B | -550.00M | 174.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -910.00M | -1.14B | -915.00M | -846.00M | -1.52B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -160.00M | -162.00M | -164.00M | -175.00M | -156.00M |
| Other Financing Activities | -155.00M | -169.00M | -199.00M | -394.00M | -478.00M |
| Cash from Financing | -1.04B | -1.13B | -1.20B | -725.00M | -1.84B |
| Foreign Exchange rate Adjustments | 6.00M | -6.00M | 0.00 | 7.00M | 13.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.00M | 29.00M | 20.00M | -66.00M | -91.00M |